Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kava banned in UK

This article was originally published in The Tan Sheet

Executive Summary

Order prohibiting sale, supply, import of kava medicinal products will take effect in UK on January 13, Medicines Control Agency announces. Following examination of 70 reports of adverse liver reactions due to kava consumption - four cases resulting in death, seven in transplants - MCA "concluded that there is clear evidence linking kava...with rare cases of liver disease." However, agency notes it will review the ban in two years to assess whether it remains justified, and can review decision "at any time if new evidence emerges." The UK dietary supplement industry initially agreed to pull kava supplements from store shelves in December 2001 (1"The Tan Sheet" Dec. 24, 2001, p. 14)...

You may also be interested in...



British Health Agency Revisits Kava Ban, Seeks Toxicity Data

Information on kava's mechanism of toxicity is being sought by the Medicines & Healthcare products Regulatory Agency as part of its review of the UK's current ban on sales of the ingredient

Déjà vu? MHRA reviews kava

The Medicines & Healthcare products Regulatory Agency will conduct a formal 12-week "public consultation exercise" in January 2005 to assess "whether the controls on kava kava remain justified and proportionate" and to "review the evidence relating to the hepatotoxicity" of the herbal, the UK health agency announces Aug. 11. The ban on kava in unlicensed herbal medicines took effect in January 2003 following reports of liver damage associated with the ingredient's consumption (1"The Tan Sheet" Jan. 6, 2003, In Brief). Health ministers who prohibited kava's sale requested the two-year follow-up. MHRA will formally write to interest groups for comment in January...

UK kava ban “folly”

National Institute of Medical Herbalists condemns UK decision to ban kava as "pure folly," noting Medicines Control Agency ruling "is totally at odds with the evidence available...[and] will harm more patients than it's supposed to protect." In 1Jan. 13 NIMH release, group maintains previous cases of liver toxicity linked to kava "have referred to the use of concentrated extracts rather than the safe traditional use of the herb." Group has started petition and letter-writing campaign to encourage MCA to remove kava ban now in effect (2"The Tan Sheet" Jan. 6, 2003, In Brief)...

Related Content

Topics

UsernamePublicRestriction

Register

OM007836

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel